Cargando…
Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study
SARS-CoV-2 vaccination is strongly recommended, particularly for fragile patients such as those undergoing active oncological treatments. It is crucial to conduct post-marketing surveillance in this patient population. In our study, we conducted a retrospective analysis of real-world data, including...
Autores principales: | Montella, Liliana, Dell’Aversana, Carmela, Pacella, Daniela, Troise, Simona, Russo, Paola, Cacciapuoti, Valentina, Ottaiano, Alessandro, Di Marino, Luigi, Coppola, Paola, Liguori, Carmela, Berretta, Massimiliano, Maddaluno, Salvatore, Altucci, Lucia, Facchini, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583381/ https://www.ncbi.nlm.nih.gov/pubmed/37848958 http://dx.doi.org/10.1186/s13027-023-00532-9 |
Ejemplares similares
-
miRNA-mediated deregulation in leukemia
por: Dell’Aversana, Carmela, et al.
Publicado: (2012) -
Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018) -
Breast Cancer Vaccines: New Insights
por: Benedetti, Rosaria, et al.
Publicado: (2017) -
HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019) -
Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells
por: Laterza, Maria Maddalena, et al.
Publicado: (2021)